Compare INSP & ITGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INSP | ITGR |
|---|---|---|
| Founded | 2007 | 1970 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8B | 2.6B |
| IPO Year | 2018 | 2000 |
| Metric | INSP | ITGR |
|---|---|---|
| Price | $118.47 | $74.08 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 17 | 8 |
| Target Price | ★ $134.38 | $93.71 |
| AVG Volume (30 Days) | ★ 2.0M | 600.1K |
| Earning Date | 11-03-2025 | 10-23-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 34.77 | N/A |
| EPS | 1.48 | ★ 2.42 |
| Revenue | $882,622,000.00 | ★ $1,831,074,000.00 |
| Revenue This Year | $14.97 | $9.58 |
| Revenue Next Year | $11.81 | N/A |
| P/E Ratio | $78.25 | ★ $30.48 |
| Revenue Growth | ★ 16.81 | 9.54 |
| 52 Week Low | $70.77 | $62.00 |
| 52 Week High | $216.01 | $146.36 |
| Indicator | INSP | ITGR |
|---|---|---|
| Relative Strength Index (RSI) | 51.62 | 54.54 |
| Support Level | $113.03 | $72.17 |
| Resistance Level | $147.03 | $73.49 |
| Average True Range (ATR) | 7.99 | 1.63 |
| MACD | -3.25 | 1.03 |
| Stochastic Oscillator | 16.00 | 82.12 |
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.
Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The company also develops batteries used in nonmedical applications in the energy, military, and environmental markets. The firm organizes itself into one segment and derives its revenues from three product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation and Other Markets. The company earns more than half of its revenue in the United States.